Insider · CIK 0001223000
John W Kozarich
director
Files at LGND (LIGAND PHARMACEUTICALS INC). First filing Jul 11, 2025, latest Dec 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $519k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LGND: LIGAND PHARMACEUTICALS INC
LGNDOct 9, 2026 · close 301.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | LIGAND PHARMACEUTICALS INC | $91k 467 shares | -1% | +104% from low-6% from high | |
| 19Weak | LIGAND PHARMACEUTICALS INC | $89k 467 shares | -1% | +98% from low-0% from high | |
| 12Weak | LIGAND PHARMACEUTICALS INC | $84k 467 shares | -1% | +85% from low0% from high | |
| 3Weak | LIGAND PHARMACEUTICALS INC | $76k 467 shares | -1% | +69% from low0% from high | |
| 2Weak | LIGAND PHARMACEUTICALS INC | $62k 467 shares | -1% | +37% from low-6% from high | |
| 5Weak | LIGAND PHARMACEUTICALS INC | $117k 934 shares | -2% | +29% from low-4% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -92 | $193.86 | $18k | 44,496 | Dec 3, 2025 |
| Dec 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -179 | $194.76 | $35k | 44,317 | Dec 3, 2025 |
| Dec 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -47 | $195.80 | $9,203 | 44,270 | Dec 3, 2025 |
| Dec 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -4 | $196.35 | $785 | 44,266 | Dec 3, 2025 |
| Dec 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -92 | $197.72 | $18k | 44,174 | Dec 3, 2025 |
| Dec 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -23 | $199.22 | $4,582 | 44,151 | Dec 3, 2025 |
| Dec 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -30 | $200.02 | $6,000 | 44,121 | Dec 3, 2025 |
| Nov 3, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -84 | $189.00 | $16k | 44,971 | Nov 5, 2025 |
| Nov 3, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -49 | $190.26 | $9,323 | 44,922 | Nov 5, 2025 |
| Nov 3, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -207 | $191.25 | $40k | 44,715 | Nov 5, 2025 |
| Nov 3, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -127 | $192.38 | $24k | 44,588 | Nov 5, 2025 |
| Oct 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -24 | $177.60 | $4,263 | 45,498 | Oct 3, 2025 |
| Oct 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -196 | $178.41 | $35k | 45,302 | Oct 3, 2025 |
| Oct 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -155 | $180.01 | $28k | 45,147 | Oct 3, 2025 |
| Oct 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -92 | $181.18 | $17k | 45,055 | Oct 3, 2025 |
| Sep 2, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -267 | $161.51 | $43k | 45,722 | Sep 4, 2025 |
| Sep 2, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -115 | $162.52 | $19k | 45,607 | Sep 4, 2025 |
| Sep 2, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -85 | $164.25 | $14k | 45,522 | Sep 4, 2025 |
| Aug 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -467 | $131.88 | $62k | 45,989 | Aug 5, 2025 |
| Jul 10, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -934 | $125.00 | $117k | 46,456 | Jul 11, 2025 |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +1,209 | $0.00 | $0 | 47,390 | Jun 10, 2025 |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +5,783 | $0.00 | $0 | 5,783 | Jun 10, 2025 |
| Jan 17, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Common Stock | +2,406 | $52.30 | $126k | 46,181 | Jun 2, 2025 |
| Jan 17, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -2,406 | $0.00 | $0 | 0 | Jun 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.